{"organizations": [], "uuid": "61e702939107884cea1c6f7dd645dfdcb35832cb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-dermapharm-says-total-proceeds-in/brief-dermapharm-says-total-proceeds-in-share-sale-will-amount-to-377-mln-eur-idUSFWN1PY1KB", "country": "US", "domain_rank": 408, "title": "BRIEF-Dermapharm says total proceeds in share sale will amount to 377 mln eur", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-09T02:50:00.000+02:00", "replies_count": 0, "uuid": "61e702939107884cea1c6f7dd645dfdcb35832cb"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-dermapharm-says-total-proceeds-in/brief-dermapharm-says-total-proceeds-in-share-sale-will-amount-to-377-mln-eur-idUSFWN1PY1KB", "ord_in_thread": 0, "title": "BRIEF-Dermapharm says total proceeds in share sale will amount to 377 mln eur", "locations": [], "entities": {"persons": [], "locations": [{"name": "frankfurt", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - Dermapharm Holding Se:\n* SAYS ‍SETS OFFER PRICE AT EUR 28.00 PER SHARE​ * SAYS ‍ALL OF 13,455,000 OFFERED SHARES IN DERMAPHARM WERE PLACED​\n* SAYS ‍3,840,000 ARE NEWLY ISSUED SHARES FROM A CAPITAL INCREASE AND 9,615,000 ARE SHARES FROM HOLDINGS OF SELLING SHAREHOLDER, INCLUDING 1,755,000 SHARES FOR OVER-ALLOTMENTS​\n* SAYS ‍ASSUMING A FULL EXERCISE OF GREENSHOE OPTION, TOTAL GROSS PROCEEDS WILL AMOUNT TO APPROX. EUR 377 MILLION​\n* SAYS ‍THEREOF, GROSS PROCEEDS OF APPROX. EUR 108 MILLION WILL BE ATTRIBUTABLE TO DERMAPHARM​ Source text for Eikon: Further company coverage: (Frankfurt newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-09T02:50:00.000+02:00", "crawled": "2018-02-09T16:45:28.031+02:00", "highlightTitle": ""}